Skip to main
VTGN
VTGN logo

VistaGen Therapeutics (VTGN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy VistaGen Therapeutics (VTGN) Stock

About VistaGen Therapeutics (VTGN)

Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site ant...read more
Market cap$72.6M
Yesterday's volume65
Revenue (TTM)$698.3K
Avg. daily volume183.36K
EBITDA (TTM)-$52.22M
Open$2.47
Price / earnings ratio-1.57x
Yesterday's range$2.43 - $2.63
Debt / equity2.11x
52 week range$1.9 - $4.21
5 year debt / equity5.6x
Beta (LTM)0.73x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio9.35x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

VistaGen Therapeutics Stock Rating

What analysts recommend for VTGN stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 57%
Buy 29%
Hold 14%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 09, 2025, the market cap for VTGN stock is $72.61M

The current P/E ratio for VTGN stock is -1.57

The 52-week high for VTGN stock is $4.21. The current VTGN stock price $undefined is 100.00% below its 52-week high

The 52-week low for VTGN stock is $1.90. The current VTGN stock price $undefined has increased 100.00% from its 52-week low

No, the VTGN stock does not pay dividends to its shareholders

The target price for VTGN stock is $11.24 based on the average of what a group of analyst think VTGN stock could be worth at a future date. This is not a prediction by Public.com

How to buy VTGN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in VTGN stock

    Navigate to the Explore page. Then, type VTGN into the search bar. When you see VTGN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased VTGN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

VistaGen Therapeutics Stock Earnings

The value each VTGN share was expected to gain vs. the value that each VTGN share actually gained.

VistaGen Therapeutics (VTGN) reported Q4 2025 earnings per share (EPS) of -$0.44, beating estimates of -$0.49 by 10.20%. In the same quarter last year, VistaGen Therapeutics's earnings per share (EPS) was -$0.25. VistaGen Therapeutics is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of -$0.44.

Buy VistaGen Therapeutics (VTGN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.